Psychosocial interventions for cannabis use disorder

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 5, 2016, Pages

  Gates, Peter J ^a   Sabioni, Pamela ^b   Copeland, Jan ^a   Le Foll, Bernard ^b   Gowing, Linda ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS;

AUSTRALIA; BRAZIL; CANADA; CANNABIS ADDICTION; COCHRANE LIBRARY; COGNITIVE BEHAVIORAL THERAPY; DRUG DEPENDENCE TREATMENT; EMBASE; FOLLOW UP; GERMANY; HUMAN; INFORMATION RETRIEVAL; IRELAND; MEDITATION; MEDLINE; MINDFULNESS BASED MEDITATION; MOTIVATIONAL ENHANCEMENT THERAPY; OUTCOME ASSESSMENT; PATIENT COUNSELING; PATIENT EDUCATION; PHARMACEUTICAL CARE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; PSYCINFO; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SWITZERLAND; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNITED STATES; AMBULATORY CARE; COGNITIVE THERAPY; MARIJUANA ABUSE; META ANALYSIS; MOTIVATIONAL INTERVIEWING; PSYCHOLOGY;

AMBULATORY CARE; COGNITIVE THERAPY; HUMANS; MARIJUANA ABUSE; MOTIVATIONAL INTERVIEWING; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84965081824     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD005336.pub4     Document Type: Review

References (196)

1. Bernstein E, Edwards E, Dorfman D, Heeren T, Bliss C, Bernstein J. Screening and brief intervention to reduce marijuana use among youth and young adults in a paediatric emergency department. Academic Emergency Medicine 2009;16(11):1174-85.
2. Bonsack C, Gibellini Manetti S, Favrod J, Montagrin Y, Besson J, Bovet P, et al. Motivational intervention to reduce cannabis use in young people with psychosis: a randomized controlled trial. Psychotherapy and Psychosomatics 2011;80(5):287-97.
3. Bonsack C, Montagrin Y, Favrod J, Gibellini S, Conus P. Motivational interviewing for cannabis users with psychotic disorders. Encephale 2007;33(5):819-26.
4. Bonsack C, Montagrin Y, Gibellini S, Favrod J, Besson J, Conus P. Practice of a motivational intervention for cannabis users with psychosis. Schweizer Archiv fur Neurologie und Psychiatrie 2008;159(6):378-85.
5. Budney AJ, Higgins ST, Radonovich KJ, Novy PL. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. Journal of Consulting and Clinical Psychology 2000;68(6):1051-61.
6. Moore BA, Budney AJ. Abstinence at intake for marijuana dependence treatment predicts response. Drug and Alcohol Dependence 2002;67(3):249-57.
7. Budney AJ, Moore BA, Rocha HL, Higgins ST. Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependence. Journal of Consulting and Clinical Psychology 2006;74(2):307-16.
8. Carroll KM, Easton CJ, Nich C, Hunkele KA, Neavins TM, Sinha R, et al. The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence. Journal of Consulting and Clinical Psychology 2006;74(5):955-66.
9. Easton CJ, Oberleitner LM, Scott MC, Crowley MJ, Babuscio TA, Carroll KM. Differences in treatment outcome among marijuana-dependent young adults with and without antisocial personality disorder. American Journal of Drug and Alcohol Abuse 2012;38(4):305-13.
10. Montgomery L, Petry NM, Carroll KM. Moderating effects of race in clinical trial participation and outcomes among marijuana-dependent young adults. Drug and Alcohol Dependence 2012;126(3):333-9.
11. Olmstead TA, Sindelar JL, Easton CJ, Carroll KM. The cost-effectiveness of four treatments for marijuana dependence. Addiction 2007;102(9):1443-53.
12. Carroll KM, Nich C, Lapaglia DM, Peters EN, Easton CJ, Petry NM. Combining cognitive behavioral therapy and contingency management to enhance their effects in treating cannabis dependence: less can be more, more or less. Addiction 2012;107(9):1650-9.
13. Kober H, DeVito EE, DeLeone CM, Carroll KM, Potenza MN. Cannabis abstinence during treatment and one-year follow-up: relationship to neural activity in men. Neuropsychopharmacology 2014;39(10):2288-98.
14. Peters EN, Nich C, Carroll KM. Primary outcomes in two randomized controlled trials of treatments for cannabis use disorders. Drug and Alcohol Dependence 2011;118:408-16.
15. Peters EN, Petry NM, Lapaglia DM, Reynolds B, Carroll KM. Delay discounting in adults receiving treatment for marijuana dependence. Experimental and Clinical Psychopharmacology 2013;21(1):46-54.
16. Copeland J, Swift W, Rees V. Clinical profile of participants in a brief cognitive-behavioral interventions for cannabis use disorder. Journal of Substance Abuse Treatment 2001;20(1):45-52.
17. Copeland J, Swift W, Roffman R, Stephens R. A randomised controlled trial of brief cognitive-behavioral interventions for cannabis use disorder. Journal of Substance Abuse Treatment 2001;21(2):55-64.
18. de Dios MA, Herman DS, Britton WB, Hagerty CE, Anderson BJ, Stein MD. Motivational and mindfulness intervention for young adult female marijuana users. Journal of Substance Abuse Treatment 2012;42(1):56-64.
19. Edwards J, Elkins K, Hinton M, Harrigan SM, Donovan K, Athanasopoulos O, et al. Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatrica Scandinavica 2006;114(2):109-17.
20. Fischer B, Dawe M, McGuire F, Shuper PA, Capler R, Bilsker D, et al. Feasibility and impact of brief interventions for frequent cannabis users in Canada. Journal of Substance Abuse Treatment 2013;44(1):132-8.
21. Fischer B, Jones W, Shuper P, Rehm J. 12-Month follow-up of an exploratory 'brief intervention' for high-frequency cannabis users among Canadian university students. Substance Abuse Treatment Prevention and Policy 2012;7:15.
22. Hoch E, Buhringer G, Henker J, Rohrbacher H, Noack R, Pixa A, et al. Design of the CANDIS-study for the treatment of cannabis use disorders: an example of translational research. Sucht 2011;57(3):183-92.
23. Hoch E, Noack R, Henker J, Pixa A, Hofler M, Behrendt S, et al. Efficacy of a targeted cognitive-behavioral treatment program for cannabis use disorders (CANDIS). European Neuropsychopharmacology 2012;22(4):267-80.
24. Hoch E, Bühringer G, Pixa A, Dittmer K, Henker J, Seifert A, et al. CANDIS treatment program for cannabis use disorders: findings from a randomized multi-site translational trial. Drug and Alcohol Dependence 2014;134:185-93.
25. Jungerman FS, Andreoni S, Laranjeira R. Short term impact of same intensity but different duration interventions for cannabis users. Drug and Alcohol Dependence 2007;90:120-7.
26. Kadden RM, Litt MD, Kabela-Cormier E, Petry NM. Abstinence rates following behavioral treatments for marijuana dependence. Addictive Behaviors 2007;32:1220-36.
27. Lee CM, Kilmer JR, Neighbors C, Atkins DC, Zheng C, Walker DD, et al. Indicated prevention for college student marijuana use: a randomized controlled trial. Journal of Consulting and Clinical Psychology 2013;81(4):702-9.
28. Litt MD, Kadden RM, Petry NM. Behavioral treatment for marijuana dependence: randomized trial of contingency management and self-efficacy enhancement. Addictive Behaviors 2013;38(3):1764-75.
29. Madigan K, Lawlor E, Brennan D, Turner N, Kinsella A, O'Connor J, et al. A multi-centre, randomised controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness. Schizophrenia Research 2013;143(1):138-42.
30. Banes KE, Stephens RS, Blevins CE, Walker DD, Roffman RA. Changing motives for use: outcomes from a cognitive-behavioral intervention for marijuana-dependent adults. Drug and Alcohol Dependence 2014;139:41-6.
31. Buckner JD, Carroll KM. Effect of anxiety on treatment presentation and outcome: results from the Marijuana Treatment Project. Psychiatry Research 2010;178(3):493-500.
32. Gibbons CJ, Nich C, Steinberg K, Roffman RA, Corvino J, Babor TF, et al. Treatment process, alliance and outcome in brief versus extended treatments for marijuana dependence. Addiction 2010;105(10):1799-808.
33. Litt MD, Kadden RM, Kabela-Cormier E, Petry NM. Coping skills training and contingency management treatments for marijuana dependence: exploring mechanisms of behavior change. Addiction 2008;103(4):638-48.
34. Litt MD, Kadden RM, Stephens RS. Coping and self-efficacy in marijuana treatment: results from the marijuana treatment project. Journal of Consulting and Clinical Psychology 2005;73(6):1015-25.
35. Peters EN, Nich C, Carroll KM. Primary outcomes in two randomized controlled trials of treatments for cannabis use disorders. Drug and Alcohol Dependence 2011;118:408-16.
36. Stephens RS, Babor TF, Kadden R, Miller M, Marijuana Treatment Project Research Group. The Marijuana Treatment Project: rationale, design and participant characteristics. Addiction 2002;97(Suppl 1):109-24.
37. The Marijuana Treatment Project Research Group. Brief treatments for cannabis dependence: findings from a randomized multisite trial. Journal of Consulting and Clinical Psychology 2004;72(3):455-66.
38. Vendetti J, McRee B, Miller M, Christiansen K, Herrell J, Marijuana Treatment Project Research Group. Correlates of pre-treatment drop-out among persons with marijuana dependence. Addiction 2002;97(Suppl 1):125-34.
39. Roffman RA, Stephens RS, Simpson EE, Whitaker DL. Treatment of marijuana dependence: preliminary results. Journal of Psychoactive Drugs 1988;20(1):129-37.
40. Stein MD, Hagerty CE, Herman DS, Phipps MG, Anderson BJ. A brief marijuana intervention for non-treatment-seeking young adult women. Journal of Substance Abuse Treatment 2011;40(2):189-98.
41. Roffman RA, Klepsch R, Wertz JS, Simpson EE, Stephens RS. Predictors of attrition from an outpatient marijuana-dependence counseling program. Addictive Behaviors 1993;18(5):553-66.
42. Stephens RE, Wertz JS, Roffman RA. Predictors of marijuana treatment outcomes: the role of self-efficacy. Journal of Substance Abuse 1993;5(4):341-53.
43. Stephens RS, Roffman RA, Simpson EE. Treating adult marijuana dependence: a test of the relapse prevention model. Journal of Consulting and Clinical Psychology 1994;62(1):92-9.
44. Stephens RS, Wertz JS, Roffman RA. Self-efficacy and marijuana cessation: a construct validity analysis. Journal of Consulting and Clinical Psychology 1995;63(6):1022-31.
45. DeMarce JM, Stephens RS, Roffman RA. Psychological distress and marijuana use before and after treatment: testing cognitive-behavioral matching hypotheses. Addictive Behaviors 2005;30(5):1055-9.
46. Stephens RS, Roffman RA, Curtin L. Comparison of extended versus brief treatments for marijuana use. Journal of Consulting and Clinical Psychology 2000;68(5):898-908.
47. Stephens RS, Roffman RA, Fearer SA, Williams C, Burke RS. The Marijuana Check-up: promoting change in ambivalent marijuana users. Addiction 2007;102(6):947-57.
48. Amaro H, Spear S, Vallejo Z, Conron K, Black DS. Feasibility, acceptability, and preliminary outcomes of a mindfulness-based relapse prevention intervention for culturally-diverse, low-income women in substance use disorder treatment. Substance Use and Misuse 2014;49(5):547-59.
49. Andersen MD. Personalized nursing: an effective intervention model for use with drug-dependent women in an emergency room. International Journal of Addiction 1986;21(1):105-22.
50. Babor TF, Webb C, Burleson JA, Kaminer Y. Subtypes for classifying adolescents with marijuana use disorders: construct validity and clinical implications. Addiction 2002;97(Suppl 1):58-69.
51. Baker A, Lewin T, Reichler H, Clancy R, Carr V, Garrett R, et al. Evaluation of a motivational interview for substance use within psychiatric in-patient services. Addiction 2002;97(10):1329-37.
52. Barrowclough C. Psychological intervention for cannabis misuse in psychosis. Schizophrenia Research 2006;86:S26-7.
53. Battjes RJ, Gordon SM, O'Grady KE, Kinlock TW, Katz EC, Sears EA. Evaluation of a group-based substance abuse treatment program for adolescents. Journal of Substance Abuse Treatment 2004;27:123-34.
54. Bellack AS, Bennett ME, Gearon JS, Brown CH, Yang YA. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Archives of General Psychiatry 2006;63(4):426-32.
55. Blevins CE, Stephens RS, Walker DD, Roffman RA. Situational determinants of use and treatment outcomes in marijuana dependent adults. Addictive Behaviors 2014;39(3):546-52.
56. Bowen S, Witkiewitz K, Dillworth TM, Blume AW, Chawla N, Simpson TL, et al. Mindfulness meditation and substance use in an incarcerated population. Psychology of Addictive Behaviors 2006;20(3):343-7.
57. Bucci S, Baker A, Halpin SA, Hides L, Lewin TJ, Carr VJ, et al. Intervention for cannabis use in young people at ultra high risk for psychosis and in early psychosis. Mental Health and Substance Use: Dual Diagnosis 2010;3(1):66-73.
58. Buchan BJ, Dennis M, Tims FM, Diamond GS. Cannabis use: consistency and validity of self-report, on-site urine testing and laboratory testing. Addiction 2002;97(Suppl 1):98-108.
59. Buchowski MS, Meade NN, Charboneau E, Park S, Dietrich MS, Cowan RL, et al. Aerobic exercise training reduces cannabis craving and use in non-treatment seeking cannabis-dependent adults. PLoS ONE 2011;6(3):e17465.
60. Burleson JA, Kaminer Y. Self-efficacy as a predictor of treatment outcome in adolescent substance use disorders. Addictive Behaviors 2005;30(9):1751-64.
61. Chang B-H, Sommers E. Acupuncture and relaxation response for craving and anxiety reduction among military veterans in recovery from substance use disorder. The American Journal on Addictions 2014;23(2):129-36.
62. Chariot P, Lepresle A, Lefevre T, Boraud C, Barthes A, Tedlaouti M. Alcohol and substance screening and brief intervention for detainees kept in police custody. A feasibility study. Drug and Alcohol Dependence 2014;134:235-41.
63. Christoff ADO, Boerngen-Lacerda R. Reducing substance involvement in college students: a three-arm parallel-group randomized controlled trial of a computer-based intervention. Addictive Behaviors 2015;45:164-71.
64. Comely C. Assessment and treatment of cannabis abuse and dependence - a practitioner's perspective. Australian Journal of Psychology 2006;58:125.
65. Copeland J, Maxwell JC. Cannabis treatment outcomes among legally coerced and non-coerced adults. BMC Public Health 2007;7:111.
66. Copeland J. Brief personalised motivational interviewing reduces frequency of marijuana use in regular users ambivalent to change. Evidence Based Mental Health 2008;11(1):22.
67. Croquette-Krokar M, Cascone P, Liengme N, Chinet L. Cannabis abuse in adolescents. A comparison of clients attending two specific psychotherapeutic units using a common assessment instrument. European Psychiatry 2004;19:160S.
68. Dau W, Schmidt A, Schmidt AF, Krug T, Lapple SE, Banger M. Five minutes a day: compass - a short psychotherapeutic intervention for young cannabis/party drug inpatients. Sucht 2011;57(3):203-14.
69. de Gee EA, Verdurmen JE, Bransen E, de Jonge JM, Schippers GM. A randomized controlled trial of a brief motivational enhancement for non-treatment-seeking adolescent cannabis users. Journal of Substance Abuse Treatment 2014;47(3):181-8.
70. Elliott JC, Carey KB, Vanable PA. A preliminary evaluation of a web-based intervention for college marijuana use. Psychology of Addictive Behaviors 2014;28(1):288-93.
71. Faulkner N, McCambridge J, Slym RL, Rollnick S. It ain't what you do, it's the way that you do it: a qualitative study of advice for young cannabis users. Drug and Alcohol Review 2009;28(2):129-34.
72. Fohlmann A, Hjorthoj C, Nordentoft M, Madsen MTR, Larsen AM. The CapOpus treatment model - a specialized 6-month treatment program for young outpatients with cannabis abuse and psychosis. Early Intervention in Psychiatry 2008;2:A121.
73. Fohlmann AH, Hjorthoej C, Larsen A, Nordentoft M. CapOpus. Randomized clinical trial: specialized addiction treatment (MI & CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry 2010;4:160.
74. Gantner A. Multidimensional family therapy for adolescent clients with cannabis use disorders - Results and experience from the INCANT pilot study. Praxis der Kinderpsychologie und Kinderpsychiatrie 2006;55(7):520-32.
75. Gantner A, Spohr B. Multidimensional family therapy in practice: clinical experiences with adolescent cannabis abusers and their families. Sucht 2010;56(1):71-6.
76. Gmel G, Gaume J, Bertholet N, Flückiger J, Daeppen JB. Effectiveness of a brief integrative multiple substance use intervention among young men with and without booster session. Journal of Substance Abuse Treatment 2013;44(2):231-40.
77. Godley SH, Garner BR, Passetti LL, Funk RR, Dennis ML, Godley MD. Adolescent outpatient treatment and continuing care: main findings from a randomized clinical trial. Drug and Alcohol Dependence 2010;110:44-54.
78. Godley MD, Godley SH, Dennis ML, Funk RR, Passetti LL, Petry NM. A randomized trial of assertive continuing care and contingency management for adolescents with substance use disorders. Journal of Consulting and Clinical Psychology 2014;82(1):40-51.
79. Gonzalez-Menendez A, Fernandez P, Rodriguez F, Villagra P. Long-term outcomes of acceptance and commitment therapy in drug-dependent female inmates: a randomized controlled trial. International Journal of Clinical and Health Psychology 2014;14(1):18-27.
80. Gray E, McCambridge J, Strang J. The effectiveness of motivational interviewing delivered by youth workers in reducing drinking, cigarette and cannabis smoking among young people: quasi-experimental pilot study. Alcohol and Alcoholism 2005;40(6):535-9.
81. Grow JC. Effects of a pretreatment brief motivational intervention on treatment engagement in CBT-based and mindfulness-based relapse prevention. Dissertation Abstracts International: Section B: The Sciences and Engineering 2014; Vol. 72, issue 2-B(E).
82. Haller DM, Meynard A, Lefebvre D, Tylee A, Narring F, Broers B. Brief intervention addressing excessive cannabis use in young people consulting their GP: a pilot study. British Journal of General Practice 2009;59(560):166-72.
83. Hathaway AD, Callaghan RC, Macdonald S, Erickson PG. Cannabis dependence as a primary drug use-related problem: the case for harm reduction-oriented treatment options. Substance Use and Misuse 2009;44(7):990-1008.
84. Hendriks VM, Schee E, Blanken P. Multidimensional family therapy and cognitive behavioral therapy in adolescents with a cannabis use disorder: a randomised controlled study. Tijdschrift voor Psychiatrie 2013;55(10):747-59.
85. Hendriks V, Schee E, Blanken P. Treatment of adolescents with a cannabis use disorder: main findings of a randomized controlled trial comparing multidimensional family therapy and cognitive behavioral therapy in The Netherlands. Drug and Alcohol Dependence 2011;119:64-71.
86. Hides LM, Elkins KS, Scaffidi A, Cotton SM, Carroll S, Lubman DI. Does the addition of integrated cognitive behaviour therapy and motivational interviewing improve the outcomes of standard care for young people with comorbid depression and substance misuse?. Medical Journal of Australia 2011;195(S3):S31-7.
87. Hides L, Carroll S, Scott R, Cotton S, Baker A, Lubman DI. Quik fix: a randomized controlled trial of an enhanced brief motivational interviewing intervention for alcohol/cannabis and psychological distress in young people. Psychotherapy and Psychosomatics 2013;82(2):122-4.
88. Hill KP, Toto LH, Lukas SE, Weiss RD, Trksak GH, Rodolico JM, et al. Cognitive behavioral therapy and the nicotine transdermal patch for dual nicotine and cannabis dependence: a pilot study. American Journal on Addictions 2013;22(3):233-8.
89. Hjorthoj C, Fohlmann A, Larsen AM, Madsen MT, Vesterager L, Gluud C, et al. Design paper: the CapOpus trial: a randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Trials 2008;9:42.
90. Hjorthoj C, Nordentoft M, Fohlmann A, Madsen MTR, Larsen AM. Preliminary results of the CapOpus trial comparing specialized treatment with treatment as usual for cannabis misuse in people with comorbid psychosis and cannabis misuse. Early Intervention in Psychiatry 2008;2:A122.
91. Hjorthoj C, Fohlmann A, Mette Larsen A, Gluud C, Arendt M, Nordentoft M. CapOpus - intervention study for cannabis use disorder in psychosis. Early Intervention in Psychiatry 2012;6:28.
92. Hjorthoj CR, Orlovska S, Fohlmann A, Nordentoft M. Psychiatric treatment following participation in the CapOpus randomized trial for patients with comorbid cannabis use disorder and psychosis. Schizophrenia Research 2013;151:191-6.
93. Huesler G, Minder W. A binational (Switzerland, Germany) intervention program for cannabis abusers. Psychology and Health 2006;21:68.
94. Hunter SB, Ramchand R, Griffin BA, Suttorp MJ, McCaffrey D, Mona A. The effectiveness of community-based delivery of an evidence-based treatment for adolescent substance use. Journal of Substance Abuse Treatment 2012;43(2):211-20.
95. Jouanne C, Phan O, Corcos M. Treatment efficacy comparison study with cannabis users or dependents adolescents: MultiDimensional Family Therapy (MDFT) versus Treatment As Usual Explicite (TAUE). Annales Medico-Psychologiques 2010;168(7):487-94.
96. Killeen TK, McRae-Clark AL, Waldrop AE, Upadhyaya H, Brady KT. Contingency management in community programs treating adolescent substance abuse: a feasibility study. Journal of Child and Adolescent Psychiatric Nursing 2012;25(1):33-41.
97. Koutras V, Iliopoulou L, Fidi E, Thomos S, Koinninou K, Gonta S, et al. Cannabis abuse treatment: a challenging aspect of an outpatient individual drug abuse therapeutic program. European Psychiatry 2008;23:S310.
98. Kraanen FL, Vedel E, Scholing A, Emmelkamp PMG. The comparative effectiveness of Integrated treatment for Substance abuse and Partner violence (I-StoP) and substance abuse treatment alone: a randomized controlled trial. BMC Psychiatry 2013;13:189.
99. Lanza PV, Garcia PF, Lamelas FR, Gonzalez-Menendez A. Acceptance and commitment therapy versus cognitive behavioral therapy in the treatment of substance use disorder with incarcerated women. Journal of Clinical Psychology 2014;70(7):644-57.
100. Laporte C, Vaillant-Roussel H, Pereira B, Blanc O, Tanguy G, Frappé P, et al. CANABIC: CANnabis and Adolescents: effect of a Brief Intervention on their Consumption - study protocol for a randomized controlled trial. Trials 2014;15:40.
101. Lee DC, Budney AJ, Brunette MF, Hughes JR, Etter JF, Stanger C. Treatment models for targeting tobacco use during treatment for cannabis use disorder: case series. Addictive Behaviors 2014;39(8):1224-30.
102. Lee D, Schroeder JR, Karschner EL, Goodwin RS, Hirvonen J, Gorelick DA, et al. Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment. American Journal on Addictions 2014;23(3):234-42.
103. Liddle H, Dakof G. A randomized controlled trial of intensive outpatient, family-based therapy vs. residential drug treatment for co-morbid adolescent substance abusers. Drug and Alcohol Dependence 2002;66:S1.
104. Litt MD, Kadden RM, Tennen H. The nature of coping in treatment for marijuana dependence: latent structure and validation of the Coping Strategies Scale. Psychology of Addictive Behaviors 26;4:791-800.
105. Lozano BE, Stephens RS, Roffman RA. Abstinence and moderate use goals in the treatment of marijuana dependence. Addiction 2006;101(11):1589-97.
106. Martin G, Copeland J. The adolescent cannabis check-up: randomized trial of a brief intervention for young cannabis users. Journal of Substance Abuse Treatment 2008;34(4):407-14.
107. McCambridge J, Strang J. The efficacy of single-session motivational interviewing in reducing drug consumption and perceptions of drug-related risk and harm among young people: results from a multi-site cluster randomized trial. Addiction 2004;99(1):39-52.
108. McCambridge J, Strang J. Deterioration over time in effect of motivational interviewing in reducing drug consumption and related risk among young people. Addiction 2005;100(4):470-8.
109. McGarvey EL, Leon-Verdin M, Bloomfield K, Wood S, Winters E, Smith J. Effectiveness of A-CRA/ACC in treating adolescents with cannabis-use disorders. Community Mental Health Journal 2014;50(2):150-7.
110. McHugo GJ, Drake RE, Teague GB, Xie H. Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services 1999;50(6):818-24.
111. Metrik J. Balanced-placebo design successfully adapted for use with marijuana. DATA: The Brown University Digest of Addiction Theory and Application 2010;29(1):8.
112. Morakinyo O. Aversion therapy of cannabis dependence in Nigeria. Drug and Alcohol Dependence 1983;12(3):287-93.
113. Morrens M, Dewilde B, Sabbe B, Dom G, De Cuyper R, Moggi F. Treatment outcomes of an integrated residential programme for patients with schizophrenia and substance use disorder. European Addiction Research 2011;17(3):154-63.
114. Murphy DA, Chen XG, Naar-King S, Parsons JT, Adolescent Trials Network. Alcohol and marijuana use outcomes in the healthy choices motivational interviewing intervention for HIV-positive youth. AIDS Patient Care and STDS 2012;26(2):95-100.
115. Nagel T, Robinson G, Condon J, Trauer T. Approach to treatment of mental illness and substance dependence in remote indigenous communities: results of a mixed methods study. The Australian Journal of Rural Health 2009;17(4):174-82.
116. Nordentoft M, Hjorthoj C, Fohlmann A. Capopus trial: an observer-blinded RCT of specialized addiction treatment versus standard treatment for young patients with cannabis abuse and psychosis. European Psychiatry 2009;24:S1178.
117. O'Farrell TJ, Murphy M, Alter J, Fals-Stewart W. Behavioral family counseling for substance abuse: a treatment development pilot study. Addictive Behaviors 2010;35(1):1-6.
118. Palfai TP, Saitz R, Winter M, Brown TA, Kypri, K, Goodness TM, et al. Web-based screening and brief intervention for student marijuana use in a university health center: pilot study to examine the implementation of eCHECKUP TO GO in different contexts. Addictive Behaviors 39;9:1346-52.
119. Phan O, Lascaux M. Motivational interviews with cannabis dependant adolescents. Annales Medico-Psychologiques 2009;167(7):523-8.
120. Phan O, Bonnaire C, Bastard N, Jouanne C. INCANT project. Psychotropes 2009;14(3-4):137-56.
121. Phan O, Jouanne C, Monge S. A random clinical trial concerning the psychotherapy of adolescents addicted to cannabis. Annales Medico-Psychologiques 2010;168(2):145-51.
122. Roy-Byrne P, Bumgardner K, Krupski A, Dunn C, Ries R, Donovan D, et al. Brief intervention for problem drug use in safety-net primary care settings: a randomized clinical trial. Journal of the American Medical Association 2014;312(5):492-501.
123. Substance Abuse and Mental Health Services Administration. SAMHSA announces advances in the treatment of adolescent marijuana users. Psychiatric Services 2000;51(11):1464.
124. Santisteban DA, Coatsworth JD, Perez-Vidal A, Kurtines WM, Schwartz SJ, LaPerriere A, et al. Efficacy of brief strategic family therapy in modifying Hispanic adolescent behavior problems and substance use. Journal of Family Psychology 2003;17(1):121-33.
125. Schaub MP, Henderson CE, Pelc I, Tossmann P, Phan O, Hendriks V, Rowe C, Rigter H. Multidimensional family therapy decreases the rate of externalising behavioural disorder symptoms in cannabis abusing adolescents: outcomes of the INCANT trial. BMC Psychiatry 2014;14:26.
126. Schnoll SH, Daghestani AN. Treatment of marijuana abuse. Psychiatric Annals 1986;16(4):249-54.
127. Schwartz RP, Gryczynski J, Mitchell SG, Gonzales A, Moseley A, Peterson TR, et al. Computerized versus in-person brief intervention for drug misuse: a randomized clinical trial. Addiction 2014;109(7):1091-8.
128. Seneviratne A, Fortini C, Gaume J, Daeppen JB. A brief motivational intervention targeting multi-risk behaviours among young people. Revue Medicale Suisse 2007;3(118):1691-4.
129. Shrier LA, Rhoads A, Burke P, Walls C, Blood EA. Real-time, contextual intervention using mobile technology to reduce marijuana use among youth: a pilot study. Addictive Behaviors 2014;39(1):173-80.
130. Sigmon SC, Steingard S, Badger GJ, Anthony SL, Higgins ST. Contingent reinforcement of marijuana abstinence among individuals with serious mental illness: a feasibility study. Experimental and Clinical Psychopharmacology 2000;8(4):509-17.
131. Sigmon SC, Higgins ST. Voucher-based contingent reinforcement of marijuana abstinence among individuals with serious mental illness. Journal of Substance Abuse Treatment 2006;30(4):291-5.
132. Simundson MD. The effectiveness of a substance abuse treatment group for at risk college students. Dissertation Abstracts International: Section B: The Sciences and Engineering 2012;73(4b):2537.
133. Sinha R, Easton C, Renee-Aubin L, Carroll KM. Engaging young probation-referred marijuana-abusing individuals in treatment: a pilot trial. American Journal of Addiction 2003;12(4):314-23.
134. Smeerdijk M, Keet R, De Haan L, Schippers G, Linszen D. Family motivation intervention in early onset psychosis and cannabis abuse: a randomized clinical trial. Schizophrenia Bulletin 2009;35:371.
135. Smith JW, Schmeling G, Knowles PL. A marijuana smoking cessation clinical trial utilizing THC-free marijuana, aversion therapy, and self-management counselling. Journal of Substance Abuse Treatment 1988;5(2):89-98.
136. Stanger C, Budney AJ, Kamon JL, Thostensen J. A randomized trial of contingency management for adolescent marijuana abuse and dependence. Drug and Alcohol Dependence 2009;105(3):240-7.
137. Stanger C, Ryan SR, Fu H, Landes RD, Jones BA, Bickel WK, et al. Delay discounting predicts adolescent substance abuse treatment outcome. Experimental and Clinical Psychopharmacology 2012;20(3):205-12.
138. Steinberg KL, Roffman RA, Carroll KM, Kabela E, Kadden R, Miller M, et al. Tailoring cannabis dependence treatment for a diverse population. Addiction 2002;97(Suppl 1):135-42.
139. Strang J, McCambridge J. Can the practitioner correctly predict outcome in motivational interviewing?. Journal of Substance Abuse Treatment 2004;27(1):83-8.
140. Swift W, Copeland J, Howard J, Roffman RA, Stephens RS, Berghuis J. Adolescent cannabis check-up and intervention trial. Drug and Alcohol Dependence 2001;63(S1):156.
141. Walker DD, Roffman RA, Stephens RS, Wakana K, Berghuis J, Kim W. Motivational enhancement therapy for adolescent marijuana users: a preliminary randomized controlled trial. Journal of Consulting and Clinical Psychology 2006;74(3):628-32.
142. Walker DD, Stephens R, Roffman R, Demarce J, Lozano B, Towe S, et al. Randomized controlled trial of motivational enhancement therapy with nontreatment-seeking adolescent cannabis users: a further test of the teen marijuana check-up. Psychology of Addictive Behaviors 2011;25(3):474-84.
143. Werder K. Addressing marijuana use as an early intervention in youth with serious mental illness. Early Intervention in Psychiatry 2012;6:97.
144. Wesley MC, Minatrea NB, Watson JC. Animal-assisted therapy in the treatment of substance dependence. Anthrozoos 2009;22(2):137-48.
145. Weymann N, Baldus C, Miranda A, More K, Reis O, Thomasius R. Trainer effects in a group training for young cannabis consumers - results of the multisite trial "CAN stop". Sucht 2011;57(3):193-202.
146. White HR, Morgan TJ, Pugh LA, Celinska K, Labouvie EW, Pandina RJ. Evaluating two brief substance-use interventions for mandated college students. Journal of Studies on Alcohol 2006;67(2):309-17.
147. Winters KC, Lee S, Botzet A, Fahnhorst T, Nicholson A. One-year outcomes and mediators of a brief intervention for drug abusing adolescents. Psychology of Addictive Behaviors 2014;28(2):464-74.
148. Wittchen H. Targeted cognitive-behavioral treatment for cannabis use disorders (CANDIS): efficacy, long term stability, and efficiency. European Neuropsychopharmacology 2010;20:s206.
149. Woolard R, Baird J, Longabaugh R, Nirenberg T, Lee CS, Mello MJ, et al. Project reduce: reducing alcohol and marijuana misuse: effects of a brief intervention in the emergency department. Addictive Behaviors 2013;38(3):1732-9.
150. Agrawal A, Budney AJ, Lynskey MT. The co-occurring use and misuse of cannabis and tobacco: a review. Addiction 2012;107(7):1221-33.
151. Australian Institute of Health and Welfare (AIHW). National Drug Strategy Household Survey detailed report 2013. Drug Statistics Series No. 28. Cat. No. PHE 183. Canberra: AIHW 2014.
152. AIHW . Alcohol and other drug treatment services in Australia 2013-14. Drug Treatment Series No. 25. Cat. No. HSE 158. Canberra: AIHW 2015.
153. Anthony JC. The epidemiology of cannabis dependence. Cannabis Dependence: Its Nature, Consequences and Treatment. Cambridge: Cambridge University Press, 2006:58-105.
154. Badiani A, Boden JM, De Pirro S, Fergusson DM, Horwood LJ, Harold GT. Tobacco smoking and cannabis use in a longitudinal birth cohort: evidence of reciprocal causal relationships. Drug and Alcohol Dependence 2015;150:69-76.
155. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 1961;4:561-71.
156. Beck AT, Wright FD, Newman CF, Liese BS. Cognitive Therapy of Substance Abuse. New York: Guilford Press, 1993.
157. Bender K, Tripodi S, Sarteschi C, Vaughn M. A meta-analysis of interventions to reduce adolescent cannabis use. Research on Social Work Practice 2011;21:153-64.
158. Budney AJ, Novy PL, Hughes JR. Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction 1999;94(9):1311-22.
159. Budney AJ, Roffman R, Stephens RS, Walker D. Marijuana dependence and its treatment. Addiction Science and Clinical Practice 2007;4(1):4-16.
160. Copeland J, Swift W, Rees V. Clinical profile of participants in a brief intervention program for cannabis use disorder. Journal of Substance Abuse Treatment 2001;20(1):45-52.
161. Copeland J, Gilmour S, Gates P, Swift W. The Cannabis Problems Questionnaire: factor structure, reliability, and validity. Drug and Alcohol Dependence 2005;80(3):313-9.
162. Copeland J, Clement N, Swift W. Cannabis use, harms and the management of cannabis use disorder. Neuropsychiatry 2014;4(1):55-63.
163. Davis ML, Powers MB, Handelsman P, Medina JL, Zvolensky M, Smits JAJ. Behavioral therapies for treatment-seeking cannabis users: a meta-analysis of randomized controlled trials. Evaluation and the Health Professions 2015;38(1):94-114.
164. American Psychiatric Association. Diagnostic and Statistical Manual. 5th ed. Arlington: American Psychiatric Association, 2013.
165. Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. A meta-analytic review of psychosocial interventions for substance use disorders. American Journal of Psychiatry 2008;165:179-87.
166. European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2014: Trends and Developments. European Drug Report 2014: Trends and Developments. Lisbon: EMCDDA, 2014.
167. European Monitoring Centre for Drugs and Drug Addiction. 2012 Annual Report on the State of the Drug Problem in Europe. Lisbon: EMCDDA, 2012.
168. Gates P, Copeland J, Swift W, Martin G. Barriers and facilitators to cannabis treatment. Drug and Alcohol Review 2012;31(3):311-9.
169. Goldstein RB, Chou SP, Smith SM, Jung J, Zhang H, Saha TD, et al. Nosologic comparisons of DSM-IV and DSM-5 alcohol and drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Journal of Studies on Alcohol and Drugs 2015;76(3):378-88.
170. Haberstick BC, Young SE, Zeiger JS, Lessem JM, Hewitt JK, Hopfer CJ. Prevalence and correlates of alcohol and cannabis use disorders in the United States: results from the National Longitudinal Study of Adolescent Health. Drug and Alcohol Dependence 2014;136(1):158-61.
171. Heather N, Luce A, Peck D, Dunbar B, James I. Development of a treatment version of the Readiness to Change Questionnaire. Addiction Research and Theory 1999;7(1):63-83.
172. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org, 2011.
173. Hindocha C, Shaban NDC, Freeman TP, Das RK, Gale G, Schafer G, et al. Associations between cigarette smoking and cannabis dependence: a longitudinal study of young cannabis users in the United Kingdom. Drug and Alcohol Dependence 2015;148:165-71.
174. Lev-Ran S, Le Strat Y, Imitiaz S, Rehm J, Le Foll B. Gender differences in prevalence of substance use disorders among individuals with lifetime exposure to substances: results from a large representative sample. American Journal on Addictions 2013;22(1):7-13.
175. Marshall K, Gowing L, Ali R, Le Foll B. Pharmacotherapies for cannabis dependence. Cochrane Database of Systematic Reviews 2014, Issue 12. [DOI: 10.1002/14651858.CD008940.pub2]
176. McLellan A, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. The Journal of Nervous and Mental Disease 1980;168(1):26-33.
177. McRae AL, Budney AJ, Brady KT. Treatment of marijuana dependence: a review of the literature. Journal of Substance Abuse Treatment 2003;24(4):369-76.
178. Mewton L, Slade T, Teesson M. An evaluation of the proposed DSM-5 cannabis use disorder criteria using Australian national survey data. Journal of Studies on Alcohol and Drugs 2013;74:614-21.
179. Miller WR, Zweben A, DiClement CC, Rychtarik RG. Motivational Enhancement Therapy Manual. NIAAA Project MATCH Monograph Series. Publication No. (ADM) 92-1894. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism, 1992.
180. Miller WR, Rollnick S. Motivational Interviewing: Preparing People to Change Addictive Behavior. New York: Guilford Press, 2002.
181. Moher D, Olkin I. Meta-analysis of randomised controlled trials. A concern for standards. JAMA 1995;274(24):1962-4.
182. Nordstrom BR, Levin FR. Treatment of cannabis use disorders: a review of the literature. The American Journal on Addictions 2010;16(5):331-42.
183. Praissman S. Mindfulness-based stress reduction: a literature review and clinician's guide. Journal of the American Academy of Nurse Practitioners 2008;20:212-6.
184. Roffman RA, Barnhart R. Assessing need for marijuana dependence treatment through an anonymous telephone interview. The International Journal of the Addictions 1987;22(7):639-51.
185. Substance Abuse and Mental Health Services Administration. Marijuana treatment admission increase: 1993-1999. The Dasis Report. Rockville, MD: Office of Applied Statistics, 2002.
186. Substance Abuse and Mental Health Services Administration. Adult marijuana admissions by race and ethnicity: 2000. The Dasis Report. Rockville, MD: Office of Applied Statistics, 2003.
187. Substance Abuse and Mental Health Services Administration. The TEDS Report: Marijuana Admissions Aged 18 to 30: Early vs. Adult Initiation. Rockville, MD: SAMHSA, 2013.
188. Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. Rockville, MD: SAMHSA, 2014.
189. Stephens RS, Roffman RA, Simpson EE. Adult marijuana users seeking treatment. Journal of Consulting and Clinical Psychology 1993;61(6):1100-4.
190. Swift W, Copeland J, Hall W. Choosing a diagnostic cut-off for cannabis dependence. Addiction 1998;93(11):1681-92.
191. Teesson M, Slade T, Swift W, Mills K, Memedovic S, Mewton L, et al. Prevalence, correlates and comorbidity of DSM-IV cannabis use and cannabis use disorders in Australia. Australian and New Zealand Journal of Psychiatry 2012;46(12):1182-92.
192. Tobler NS, Lessard T, Marshall D, Ochshorn P, Roona M. Effectiveness of school-based drug prevention programs for marijuana use. School Psychology International 1999;20(1):105-37.
193. Van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M. Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study. Drug and Alcohol Dependence 2013;133:352-9.
194. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva, Switzerland: WHO, 1992.
195. Winstock AR, Ford C, Witton J. Assessment and management of cannabis use disorders in primary care. British Medical Journal 2010;340:c1571.
196. Denis C, Lavie E, Fatseas M, Auriacombe M. Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings. Cochrane Database of Systematic Reviews 2006, Issue 3, CD005336. [DOI: 10.1002/14651858.CD005336.pub2]